Preferred Name |
Exenatide |
|
Synonyms |
|
|
Definitions |
A 39 amino acid peptide and synthetic version of exendin-4, a hormone found in the saliva of the venomous lizard Gila monster, with insulin secretagogue and antihyperglycemic activity. Exenatide is administered subcutaneously and mimics human glucagon-like peptide-1 (GLP-1). Compared to GLP-1, exenatide has a longer half-life of 2.4 hours. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C65611 |
|
CAS_Registry |
141732-76-5 141758-74-9 |
|
CHEBI_ID |
CHEBI:64073 |
|
Chemical_Formula |
C184H282N50O60S |
|
code |
C65611 |
|
Contributing_Source |
FDA |
|
definition |
A 39 amino acid peptide and synthetic version of exendin-4, a hormone found in the saliva of the venomous lizard Gila monster, with insulin secretagogue and antihyperglycemic activity. Exenatide is administered subcutaneously and mimics human glucagon-like peptide-1 (GLP-1). Compared to GLP-1, exenatide has a longer half-life of 2.4 hours. |
|
FDA_UNII_Code |
9P1872D4OL |
|
in_subset | ||
label |
Exenatide |
|
Legacy Concept Name |
Exenatide |
|
NCI_Drug_Dictionary_ID |
719492 |
|
PDQ_Closed_Trial_Search_ID |
719492 |
|
PDQ_Open_Trial_Search_ID |
719492 |
|
Preferred_Name |
Exenatide |
|
prefixIRI |
NCIT:C65611 |
|
prefLabel |
Exenatide |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0167117 |
|
subClassOf |